IBEX Technologies Inc.
IBT
Rank in Stocks
#28725
Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc.... Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc. specializes in the production and global distribution of enzymes tailored for biomedical applications. The company's reach extends to Canada, the United States, Germany, and the United Kingdom, as well as other international markets. Its extensive product catalog features recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, along with Chondroitinase AC and B. Furthermore, IBEX offers collagen ELISAs designed to investigate the synthesis and breakdown of connective tissue components, complementing these with collagen antibodies and diamine oxidase liquid. They are also a key provider of arthritis assays, essential for research into osteoarthritis. Beyond their product lines, IBEX delivers lyophilization services for disposable medical device parts, in addition to custom fermentation and contract manufacturing capabilities. Their diverse client base encompasses medical device fabricators, quality control facilities, producers of low molecular weight heparin, and academic research institutions.
Share Price
$1.05
Last synced: 2024-04-11
Market Cap
$23.31M
Change (1 day)
-0.01%
Change (1 year)
5.21%
Country
CA
Trade IBEX Technologies Inc. (IBT)
Category
Healthcare
Stock price history for IBEX Technologies Inc. (IBT)
Highest end of day price: $1.00 on 2024-04-01
Lowest end of day price: $0.18 on 2018-08-01
Lowest end of day price: $0.18 on 2018-08-01
Stock price history of IBEX Technologies Inc. from 2018 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2024 | 39.28% |
| 2023 | 66.64% |
| 2022 | 60.33% |
| 2021 | 33.14% |
| 2020 | 119.45% |
| 2019 | -31.94% |
| 2018 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.77 | -3.82% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
